Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network

A weighted bilinear neural collaborative filtering approach for drug repositioning

(2022) Yajie Meng et al.   BRIEFINGS IN BIOINFORMATICS

Drug repositioning based on multi-view learning with matrix completion

(2022) Yixin Yan et al.   BRIEFINGS IN BIOINFORMATICS

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer

(2021) Haitang Yang et al.   EBioMedicine

Biomedical data and computational models for drug repositioning: a comprehensive review

(2020) Huimin Luo et al.   BRIEFINGS IN BIOINFORMATICS

Coronavirus puts drug repurposing on the fast track

(2020) Charlotte Harrison   NATURE BIOTECHNOLOGY

iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding

(2020) Huiyuan Chen et al.   PLoS Computational Biology

Predicting drug–disease associations through layer attention graph convolutional network

(2020) Zhouxin Yu et al.   BRIEFINGS IN BIOINFORMATICS

Comparative Toxicogenomics Database (CTD): update 2021

(2020) Allan Peter Davis et al.   NUCLEIC ACIDS RESEARCH

deepDR: A network-based deep learning approach to in silico drug repositioning

(2019) Xiangxiang Zeng et al.   BIOINFORMATICS

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease

(2019) Michelle E. Melisko et al.   BREAST CANCER RESEARCH AND TREATMENT

Convolutional Neural Network and Bidirectional Long Short-Term Memory-Based Method for Predicting Drug–Disease Associations

(2019) Xuan et al.   Cells

β-2-Himachalen-6-ol inhibits 4T1 cells-induced metastatic triple negative breast carcinoma in murine model

(2019) Hamid E. Daaboul et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction

(2019) Jin Li et al.   BIOINFORMATICS

Predicting drug-disease associations with heterogeneous network embedding

(2019) Kai Yang et al.   CHAOS

NeoDTI: Neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions

(2018) Fangping Wan et al.   BIOINFORMATICS

Predicting drug-disease associations by using similarity constrained matrix factorization

(2018) Wen Zhang et al.   BMC BIOINFORMATICS

Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer

(2018) Rui-Jun Ju et al.   Artificial Cells Nanomedicine and Biotechnology

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

(2018) Vanesa Gregorc et al.   ONCOLOGIST

Drug repurposing: progress, challenges and recommendations

(2018) Sudeep Pushpakom et al.   NATURE REVIEWS DRUG DISCOVERY

Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization

(2017) Ali Ezzat et al.   IEEE-ACM Transactions on Computational Biology and Bioinformatics

Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer

(2017) Hongzhi Qiao et al.   JOURNAL OF DRUG TARGETING

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

(2016) Huimin Luo et al.   BIOINFORMATICS

The Comparative Toxicogenomics Database: update 2017

(2016) Allan Peter Davis et al.   NUCLEIC ACIDS RESEARCH

Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction

(2016) Yong Liu et al.   PLoS Computational Biology

Medical subject headings (MeSH) terms

(2014) IshKumar Dhammi et al.   Indian Journal of Orthopaedics

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

(2012) Charles M Rudin et al.   NATURE GENETICS

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

(2012) Martin Peifer et al.   NATURE GENETICS

PREDICT: a method for inferring novel drug indications with application to personalized medicine

(2011) A. Gottlieb et al.   Molecular Systems Biology

Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment

(2010) Man-Yi Wong et al.   ANTI-CANCER DRUGS

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin and paclitaxel in patients with advanced cancer

(2010) G J Rustin et al.   BRITISH JOURNAL OF CANCER

Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082

(2009) Lawrence B. Marks et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS